.Semaglutide: Novo Nordisk Semaglutide is a long-acting oral GLP-1 analogue being developed and investigated by Novo Nordisk. The drug is currently being evaluated under Phase III clinical trial for ...

Creamy, biscuity and indulgent, coffee experts at Nespresso and Oatly co-created the Oatly Barista Edition coffee – blending, ...

Former BBC broadcaster Jon Sopel has opened up about his success after leaving the BBC and revealed whether he thinks his ...

Airbnb, Inc. (NASDAQ:ABNB), the leading online marketplace for short-term rentals and experiences, finds itself at a crossroads as it navigates a challenging landscape of slowing growth, increased ...

If DeepSeek is to be believed, its AI model was crafted at a fraction of its US rivals. The dramatic impact on markets comes ...

The mutual fund industry has started to see a slowdown in equity fund flows since early December, a trend attributed to ...

Kotak Institutional reaffirms 'BUY' on IndiGo for strong performance and growth potential. Explore more about the Rs 5,100 ...

Capital One posted a messy fourth quarter, with less top-line growth than many peers. Read more to see why I rate COF stock a ...

Oil futures were lower in early Asian trading after President Trump said he wants crude prices to be lower, ANZ research ...

A trade war that raises prices would be much more complicated for the central bank than it was during Trump’s first term.

FMCG major Hindustan Unilever (HUL) reported a 19% year-on-year rise in its net profit for the fiscal third quarter ended ...